Wed, Sep 3, 2014, 4:46 AM EDT - U.S. Markets open in 4 hrs 44 mins

Recent

% | $
Quotes you view appear here for quick access.

VirnetX Holding Corp Message Board

oechman 13 posts  |  Last Activity: Aug 11, 2014 3:12 PM Member since: Sep 22, 2004
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • What the heck is going on? We are now 42 days into the Q without a lift, for those keeping score, that's $0.0 REVENUE this Q which is almost half over. Sounds like its time for more stock options and a raise for management. Remember EGY operates in the bizarro world where lack of performance is actually rewarded.
    How the heck is the share price going to grow when we can't get consistent earning and revenue growth?

    For those calling for a higher share price please put the pipe down and get with reality. I for one think its time to put the company on the selling block.

  • oechman by oechman Aug 7, 2014 10:36 AM Flag

    This company just does not miss timelines, ever.

    I thought that 5000 share buy Frost made on Aug 4th would be his last before data was released. The Rayaldee trial ended July 15th so it goes to show you how hard they worked to get the data results released as quickly as possible. FYI, on Aug 15th institutional updates will be in for the 2nd Q. Where O where will the shorts get the shares to cover? The trap is set and they are screwed.

  • oechman by oechman Aug 6, 2014 10:40 AM Flag

    Interesting that BP is helping fund a $350 million research center in Angola. Watch groups are concerned about what kind of access this will "buy" BP. They are doing this in conjunction with the state run oil company
    Sonagol. Must be some serious oil in Angola for BP to "fund" this center.

  • oechman by oechman Aug 5, 2014 5:09 PM Flag

    $1.2 million dollar consulting fee, REALLY? Hey EGY, POST THE FREAKING LIFT

  • oechman by oechman Aug 4, 2014 5:41 PM Flag

    Where's is the lift this month? Must be a holiday down in Houston.

  • oechman by oechman Aug 4, 2014 11:46 AM Flag

    Just read an article posted on AOL regarding risk factors for getting MS and the 1st one listed is low vitamin D. Folks with normal vitamin D levels are at low risk of getting MS. Did someone say Rayaldee?

  • Reply to

    Rayaldee results before earnings report?

    by haigs159 Aug 1, 2014 2:32 PM
    oechman oechman Aug 2, 2014 8:27 AM Flag

    burnaka, I believe the Rayaldee study ended in July. The good Dr. has stated on numerous occasions that the data will be released in the 3rd Q. I'll take his word for it since OPK never seems to miss a timeline. I expect data sometime in Sept

  • Reply to

    It's a good sign when Dr. Frost

    by ml.hana Jul 28, 2014 3:25 PM
    oechman oechman Jul 29, 2014 7:47 AM Flag

    Frost has been buying shares for YEARS and his buying shares last week / this week has ABSOLUTELY NOTHING to do with earnings next week. His buying has everything to do with the long term value he sees in OPK.

  • Reply to

    AMRN Market Cap Currently Appropriate

    by dendreonpro Jul 25, 2014 6:11 AM
    oechman oechman Jul 25, 2014 8:45 AM Flag

    You of course choose to ignore the major conflicts of interest that existed on the advisory panel. The FDA chose to ignore scientific evidence, which has become much stronger since their ruling, that triglycerides play a much bigger role in heart health then was previously thought.

  • Reply to

    Burnaka and others: If everything is so ·√ⁿ

    by maxirnus Jun 24, 2014 12:07 PM
    oechman oechman Jul 19, 2014 7:11 PM Flag

    Rayaldee, Rayaldee, Rayaldee, this is the drug that ushers in a new era for the company. I know you haven't forgot about the Claris buyout and I suspect the in office blood test will be ready for primetime right around the
    time we get approval for Rayaldee. OF course we have the 4k test that will be the standard and replace the PSA test. Institution ownership is nothing so once risk is taken away (see rayaldee results) they start piling in.
    Look at the Soros, MS, Goldman ext ext #'s in the 2nd quarter, updates have to be released by Aug 14th.

  • oechman by oechman Jul 4, 2014 2:02 AM Flag

    Rayaldy and the institutional update could be coming at the same time. 41 days is the half way mark for the 3rd Q and data from the PIII trial Dr Frost has stated many times will be released. 41 days until we see the updated
    institutional ownership #'s. 41 days until the shorts realize they messed with the wrong company and the wrong man. Rayaldy changes the entire matrix of this company and its an even more compelling story when you add the point of care diagnostic blood test into the future revenue mix.

    BTW, if you haven't read or just skimmed the recent release of the PII data for the hormone replacement drug, go REALLY look at it. This drug is so vastly superior to existing therapies its shocking. Best in class does not even begin to describe it. Going from memory, I believe the good Dr said this was a $1.8 billion market, can't imagine anyone in their right mind not wanting to go to once a week injection.

  • oechman oechman Jun 25, 2014 12:10 PM Flag

    In order to capture all the gains this stock has to offer, one must commit to the stock for the next 5 years.

    One of the things that is most impressive to me about this company is how the pipeline contains so little risk. In many instances they are using their technology to improve either the delivery of or the dosing schedule of existing effective, safe drugs. Can't wait for the PIII data for Rayaldy.

  • oechman by oechman Jun 11, 2014 12:40 PM Flag

    The phase 3 trials end in July and the good Dr has stated results in the 3rd quarter with filing for approval in Jan 2015. Read the bio on the marketing guy OPK hired to take this drug to market. Short away boys and girls at your peril, the PIII data is going to crush you.

VHC
14.74-0.01(-0.07%)Sep 2 4:01 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Conns Inc.
NasdaqGSTue, Sep 2, 2014 4:00 PM EDT
Compuware Corporation
NasdaqGSTue, Sep 2, 2014 4:00 PM EDT